Sanofi will take a hit this year from generic competition to blockbuster cancer drugs Eloxatin and Taxotere, as well as bloodthinners Plavix and maybe ...
Consider the following: About 72 percent of prescription drugs dispensed in this country are for generic medicines, but name-brand drugs account for about ...
Medill Reports: Chicago - Charlie Mead - 15 hours ago
“Without today's innovative brand-name drugs to legally copy, there would be no generic drug industry,” Johnson stated in an additional PhRMA release on ...
In their January sales reports, Walgreen ( WAG - news - people ) and Rite Aid ( RAD - news - people ) acknowledged that new generic drugs led to slimmer ...
The ongoing debate over generic and brand-name drugs has raged on for quite some time. However, the argument is being fueled with lighter fluid as recent ...
Federal employees, who enjoy a variety of benefits as government workers, are not getting a deal on generic drugs from the CVS chain of pharmacies if they ...
Japan is aiming for generic drugs to account for 30 percent of prescriptions by 2012, up from 20 percent in December, the country's health ministry said. ...
... Protonix(R) and Eloxatin(R), the current economic conditions, competition from brand-name companies that are under increased pressure to counter generic...
Wall Street Journal - Eyk Henning - 21 hours ago
A winning bid of up to EUR3 billion is possible, the person said, which would make it the biggest takover in the generic drugs market since Israel's Teva ...
Email this story
